Report Categories
View AllRecent Articles
View All
Eli Lilly and Company LLY Pipeline Expansion and Weight Loss Therapy Traction Drive Bullish Analyst Consensus as Top Pharma Buy
SLXN Silexion Therapeutics posts wider than expected Q4 2025 loss pushing shares 301 percent lower in todays trading
AWRE Aware falls 172 after Q1 2026 earnings release with no available analyst consensus estimates
MKC McCormick reports Q1 2026 nearly 10 percent EPS beat against estimates but shares fall 117 percent today